Agios Pharmaceuticals, Inc. (AGIO)

NASDAQ

$36.83

$+0.32

(+0.87%)

Regular Market

Agios Pharmaceuticals, Inc. (AGIO) Live Price Chart

Last updated: ⁦2026-10-21 16:01:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Agios Pharmaceuticals, Inc. (AGIO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $36.83, with a market capitalization of $2.08B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $22.24 to $46.00. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$2.08B
Open	$36.62
Day's High	$138.85
Day's Low	$15.77
Previous Close	$36.64
Volume	202.13K
Average Volume	1.10M
P/E Ratio	--
52-Week High	$46.00
52-Week Low	$22.24
Dividend Yield	--
Earnings Date	--

Agios Pharmaceuticals, Inc. (AGIO) Stock Price Today

Agios Pharmaceuticals, Inc. (AGIO) is currently trading at $36.83 as of 2026-10-21 15:59:00, up 0.52% ($0.19) from the previous close of $36.64

During today's regular trading session, AGIO has traded between $15.77 and $138.85, with a trading volume of 202.13K shares. The current price is near the lower end of today's range.

Agios Pharmaceuticals, Inc. (AGIO) 7-Day Stock Price Change

Over the past seven days, Agios Pharmaceuticals, Inc. (AGIO) moved from $30.82 to $36.83, representing a gain of 19.51% ($6.01).

The stock traded between $29.67 and $39.00 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 1.32 million shares, up versus the previous seven-day period, indicating higher trading activity.

AGIO 52-Week Price Position

Position in Range: 61.4%

52W Low$22.24

52W High$46.00

AGIO is currently trading at $36.83, placing it 61.4% of the way from its 52-week low of $22.24 to its 52-week high of $46.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Agios Pharmaceuticals, Inc. (AGIO)?

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Agios Pharmaceuticals, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	540
Exchange	NASDAQ
Company Website	https://www.agios.com

How to Buy Agios Pharmaceuticals, Inc. (AGIO) Stock on MEXC

Eligible investors can buy real shares of Agios Pharmaceuticals, Inc. (AGIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for AGIO and Place Your Order

Open the RealStocks trading page and search for AGIO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Agios Pharmaceuticals, Inc. (AGIO) stock price today?

Agios Pharmaceuticals, Inc. (AGIO) is currently trading at $ 36.83, up 0.52% ($0.19) from the previous close of $ 36.64. Intraday prices update in real time during regular trading hours.

2.Is AGIO stock going up or down today?

As of 2026-10-21 15:59:00, AGIO is trading at $ 36.83, up 0.52% ($0.19) from its previous close of $ 36.64. The stock has traded between $ 15.77 and $ 138.85 during today’s regular session. Past price movements do not guarantee future results.

3.What is AGIO pre-market price?

As of 2026-10-21 15:59:00, AGIO is trading at $ 36.97 in pre-market trading, up 0.91% ($0.33) from the previous close of $ 36.64. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is AGIO after-hours price?

As of 2026-10-21 15:59:00, AGIO is trading at $ 37.44 in after-hours trading, up 2.17% ($0.80) from the regular-session close of $ 36.64. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is AGIO stock trading now?

AGIO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does AGIO sit relative to its 52-week high and low?

Over the past 52 weeks, AGIO has traded between a low of $ 22.24 and a high of $ 46.00. At $ 36.83, the stock is positioned 61.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Agios Pharmaceuticals, Inc. in?

Agios Pharmaceuticals, Inc. (AGIO) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Agios Pharmaceuticals, Inc.'s market capitalization and where is it listed?

Agios Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 2.08B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is AGIO valued in terms of P/E ratio and EPS?

AGIO trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -6.89. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Agios Pharmaceuticals, Inc. pay a dividend?

Agios Pharmaceuticals, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.